| ¿µ¹® | Benign Prostatic Hyperplasia(BPH) | ÇÑ±Û | Àü¸³»ùºñ´ë |
|---|---|---|---|
| ¼³¸í | 50¼¼ ÀÌ»óÀÇ ³²¼º¿¡ ºó¹ßÇÏ´Â º´À¸·Î Àü¸³»ùÀÇ ¿äµµ ÁÖÀ§ ¿µ¿ª¿¡ Å«°áÀýÀ» Çü¼ºÇÏ¿©, À̰ÍÀÌ Ä¿Áö¸é ¿äµµ¸¦ ¾Ð¹ÚÇÏ¿© ºÎºÐÀû ȤÀº ¿ÏÀüÇÑ ¿äµµÆó»öÀ» ÀÏÀ¸Å°´Â º´ÀÌ´Ù. Áõ»óÀº ¿äµµÆó»ö¿¡ µû¸¥ ¼Òº¯ÀÇ °¨¼Ò¿Í ¹æ±¤ÀÚ±ØÁõ»óÀ¸·Î ºó´¢, ÀÜ´¢°¨, ¼Òº¯À» ÂüÀ» ¼ö ¾ø´Â Áõ»ó µîÀÌ´Ù. Ä¡·á´Â °æ¿äµµ Àü¸³»ù ÀûÃâ¼ú·Î Àü¸³¼±ÀÇ ºñ´ëÇÑ ºÎºÐÀ» ÀýÁ¦ÇØ¾ß ÇÑ´Ù. |
||
| ¿µ¹® | cystic fibrosis | ÇÑ±Û | ³¶¼º¼¶À¯Áõ |
|---|---|---|---|
| ¼³¸í | À¯Àüº´ÀÇ Çϳª·Î ¶¡»ù, ±â°üÁö¿¡¼ Á¡¾×À» ºÐºñÇÏ´Â »ù, ÀÌÀÚµîÀÇ ¿ÜºÐºñ»ù(¸ö ¹ÛÀ¸·Î ¾×ü¸¦ ºÐºñÇÏ´Â »ù. ³»ºÐºñ»ùÀ» Á¦¿ÜÇÑ ¸ðµç »ùÀ» À̸¥´Ù)ÀÇ ÀÌ»óÀ» Ư¡À¸·Î ÇÏ´Â º´ÀÌ´Ù. Áß¿äÇÑ º´ÀûÀÎ º¯È´Â ÁÖ·Î ±â°üÁö¿¡¼ Á¡¾×À» ºÐºñÇÏ´Â ºÐºñ»ù¿¡¼ Áö³ªÄ¡°Ô Á¡µµ°¡ ³ôÀº Á¡¾×ÀÌ ºÐºñµÇ¾î ±â°üÁö¸¦ ¸·¾Æ È£ÈíÀå¾Ö¸¦ ÀÏÀ¸Å°´Â ÆóÀÇ º´ÅÍÀ̸ç, ¶¡¿¡¼ °úµµÇÑ ÀüÇØÁú ƯÈ÷ ¿°È³ªÆ®·ý(NaCl)ÀÌ ºÐºñµÇ¾î ¸ö¿¡ ÀüÇØÁúÀÌ ºÎÁ·ÇÏ°Ô µÈ´Ù. ¶Ç ÀÌÀÚÀÇ ¼ÒȾ×À» ºÐºñÇÏ´Â ºÐºñ»ùÀÇ ÀÌ»óÀ¸·Î ÀÌÀÚ°üÀÌ ¸·È÷°Å³ª ÀÌÀÚÀÇ ±â´ÉÀÌ ¶³¾îÁ®¼ ¼ÒÈÀÇ Àå¾Ö¸¦ ÀÏÀ¸Å°±âµµ ÇÑ´Ù. À¯Å°迡 ¸¹À¸¸ç ¿ì¸®³ª¶ó¿¡´Â ¾ÆÁÖ µå¹°´Ù. |
||
| ¿µ¹® | hyperplasia | ÇÑ±Û | °ú´ÙÇü¼º, Áõ½Ä |
|---|---|---|---|
| ¼³¸í | ±â´ÉÇ×ÁøÀ» À¯¹ß½ÃŰ´Â ÀÚ±ØÀ» ¹Þ¾ÒÀ» ¶§ ºÐ¿ÀÌ °¡´ÉÇÑ ¼¼Æ÷°¡ ¼¼Æ÷ºÐ¿·Î ±× ¼ö°¡ Áõ°¡µÇ´Â °ÍÀ» Áõ½ÄÀ̶ó Çϸç, °á°úÀûÀ¸·Î ±× Á¶Á÷À̳ª Àå±âµµ Ä¿Áö°Ô µÈ´Ù. ºñ´ë´Â ´Ü¼øÈ÷ ¼¼Æ÷ÀÇ Áõ½ÄÀÌ ¾øÀÌ ¼¼Æ÷ÀÇ Å©±â°¡ Ä¿Áö´Â °æ¿ì¸¦ À̸£´Â ¸»ÀÌ´Ù. |
||
| BPH | Benign Prostate(Prostatic) Hypertrophy(Hyperplasia); Àü¸³¼± ºñ´ë(Áõ) |
|---|---|
| CFF | critical flicker fusion [test]; critical fusion frequency; cystic fibrosis factor; Cystic Fibrosis F... |
| CFP | chronic false positive; Clinical Fellowship Program; cyclophosphamide, fluorouracil, prednisone; cys... |
| MEN | Multiple Endocrine Neoplasia ; AD Trait 1. MEN Type I(= Wermer Syndro... |
| FH | facial hemihyperplasia; familial hypercholesterolemia; family history; fasting hyperbilirubinemia; f... |
| ACDK | Acquired cystic disease of the kidney |
|---|---|
| ACKD | Acquired cystic kidney disease |
| ARCD | Acquired renal cystic disease |
| ACC | Adenoid Cystic Carcinoma |
| C.C.A.M. | Congenital Cystic Adenomatoid Malformation |
| benign prostatic hyperplasia | <urology> A benign enlargement of the prostate gland begins normally after age 50 years probably secondary to the effects of male hormones. If significant enlargement occurs, it may pinch off te urethra making urination difficult or impossible. See: urinary retention. Origin: Gr. Plassein = to form (06 Aug 1998) |
|---|---|
| prostatic hyperplasia | Enlargement or overgrowth of the prostate gland as a result of an increase in the number of its constituent cells. (12 Dec 1998) |
| cystic hyperplasia | Formation of multiple retention cysts from obstruction of ducts or glands by hyperplasia of the lining epithelium, as in fibrocystic disease of the breast and metropathia haemorrhagica. (05 Mar 2000) |
| cystic hyperplasia of the breast | A benign disease common in women of the third, fourth, and fifth decades characterised by formation, in one or both breasts, of small cysts containing fluid which may appear as blue dome cysts; associated with stromal fibrosis and with variable degrees of intraductal epithelial hyperplasia and sclerosing adenosis. Synonym: cystic hyperplasia of the breast. (05 Mar 2000) |
| benign prostatic hypertrophy | <urology> A benign enlargement of the prostate gland begins normally after age 50 years probably secondary to the effects of male hormones. If significant enlargement occurs, it may pinch off te urethra making urination difficult or impossible. See: urinary retention. (06 Aug 1998) |
| cancer, prostatic | Cancer of the gland (prostate) that produces some of the components of semen fluid. The second leading cause of death of males in the U.S. Prostate cancer is often first detected as a hard nodule during a routine rectal examination. The PSA blood test is a screening test for prostate cancer. Diagnosis of prostate cancer is established when cancer cells are identified in prostate tissue obtained by a biopsy. In some patients, prostate cancer is life threatening. In many others, prostate cancer can exist for years without causing any health problems. Treatment options for prostate cancer include observation, radiation therapy, surgery, hormonal therapy, and chemotherapy. (12 Dec 1998) |
| prostatic | <anatomy> Of or pertaining to the prostate gland. Source: Websters Dictionary (01 Mar 1998) |
| prostatic adenoma | <tumour> A term used for the growth in benign prostatic hyperplasia. (05 Mar 2000) |
| prostatic calculus | <urology>A concretion formed in the prostate gland, composed chiefly of calcium carbonate and phosphate (corpora amylacea). Synonym: prostatolith. (05 Mar 2000) |
| prostatic catheter | A catheter with an angular bend near the beak; used to rise over prostatic obstruction. Synonym: catheter coude, prostatic catheter. (05 Mar 2000) |
| prostatic ducts | About 20 minute canals that receive the prostatic secretion from the glandular tubules and discharge it through openings on either side of the urethral crest in the posterior wall of the urethra. Synonym: ductuli prostatici, ductus prostatici, prostatic ducts. (05 Mar 2000) |
| prostatic ductules | About 20 minute canals that receive the prostatic secretion from the glandular tubules and discharge it through openings on either side of the urethral crest in the posterior wall of the urethra. Synonym: ductuli prostatici, ductus prostatici, prostatic ducts. (05 Mar 2000) |
| prostatic fluid | Succus prostaticus;a whitish secretion that is one of the constituents of the semen. (05 Mar 2000) |
| prostatic intraepithelial neoplasia | A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer. (12 Dec 1998) |
| prostatic massage | Manual expression of prostatic secretions by digital rectal technique, the emptying of prostatic sini and ducts by repeated downward compression manoeuvres, used in the treatment of various congestive and inflammatory prostatic conditions. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|